Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
HOUSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, announced its support for the Genomic Answers for Children’s Health...
-
American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research
-
Los Angeles, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Clean Power Alliance (CPA) and Calpine Community Energy have announced the latest group of awardees to receive funding through their annual...
-
14 janv. 2026 08h00 HE | Source: Beijing Hospital of Integrated Traditional Chinese and Western Medicine
Beijing, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Amid the bitter cold of winter, with the north wind bringing warmth, on January 9th, the "Hundred Herbs Reflecting Snow · Twenty-Four Flavors Bookstore"...
-
Chicago, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The global exosome research market was valued at US$ 280.70 million in 2025 and is expected to reach US$ 2,491.42 million by 2035 at a CAGR of 24.4% over...
-
Austin, TX, USA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neurocosmetics Market Size, Trends and Insights By Product Type (Body Care, Face...
-
Ottawa, Jan. 13, 2026 (GLOBE NEWSWIRE) -- According to Precedence Research, U.S. health care finance leaders are heading into 2026 with growing concern over external economic and policy-related...
-
LOUISVILLE, Ky., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today new development details related to its charitable gaming...
-
PHILADELPHIA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical...
-
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting
Mark Pavao to Join BioXcel Therapeutics as Interim Chief Commercial Officer Mr. Pavao Brings Deep Experience in Neuroscience Sales and Marketing to Support Potential Launch of IGALMI® in At-Home...